Olfactory Dysfunction is not a Determinant Of Patient-Reported Chronic Rhinosinusitis Disease Control
- PMID: 33300623
- DOI: 10.1002/lary.29280
Olfactory Dysfunction is not a Determinant Of Patient-Reported Chronic Rhinosinusitis Disease Control
Abstract
Objectives/hypothesis: As a cardinal symptom of chronic rhinosinusitis (CRS), hyposmia has been recommended to be assessed as a component of CRS disease control. Herein we determine the significance of hyposmia in CRS in the context of nasal obstruction and drainage symptoms.
Study design: Prospective, cross-sectional METHODS: Cross-sectional study of 308 CRS patients (102 CRSwNP, 206 CRSsNP) without prior endoscopic sinus surgery. The burden of nasal obstruction and hyposmia were assessed using the corresponding item scores on the 22-item Sinonasal Outcome Test (SNOT-22). Burden of nasal discharge was assessed using the mean of "thick nasal discharge" and "thick post-nasal discharge" SNOT-22 item scores. Patients were all asked to rate their CRS symptom control as "not at all," "a little," "somewhat," "very," or "completely."
Results: In CRSwNP, only 4.9% had a hyposmia score > 1 with nasal obstruction and drainage scores less than or equal to 1. In CRSsNP, only 1.9% had a hyposmia score > 1 with nasal obstruction and drainage scores less than or equal to 1. On univariate association, CRS symptom control was significantly associated with nasal obstruction, hyposmia, and drainage in both CRSwNP and CRSsNP (P < .05 in all cases). Using multivariable regression to account for all nasal symptoms, only nasal obstruction and nasal discharge scores (but not hyposmia) were significantly associated with CRS symptom control.
Conclusions: Hyposmia rarely occurs without nasal obstruction or nasal drainage, and may therefore be redundant to assess for CRS disease control. Moreover, hyposmia was not associated with patient-reported CRS symptom control when accounting for the burden of nasal obstruction and drainage.
Level of evidence: 3 Laryngoscope, 131:E2116-E2120, 2021.
Keywords: Chronic rhinosinusitis; anosmia; control; hyposmia; nasal obstruction; olfaction; olfactory dysfunction; rhinorrhea; smell loss.
© 2020 American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).
Comment in
-
Kommentar zu „Olfaktorische Dysfunktion eignet sich nicht als Kriterium für die Krankheitskontrolle“.Laryngorhinootologie. 2021 Sep;100(9):689-690. doi: 10.1055/a-1486-1730. Epub 2021 Aug 30. Laryngorhinootologie. 2021. PMID: 34461639 German. No abstract available.
-
Olfaktorische Dysfunktion eignet sich nicht als Kriterium für die Krankheitskontrolle.Laryngorhinootologie. 2021 Sep;100(9):689. doi: 10.1055/a-1486-1888. Epub 2021 Aug 30. Laryngorhinootologie. 2021. PMID: 34461640 German. No abstract available.
Similar articles
-
Chronic Rhinosinusitis Patients With and Without Polyps Experience Different Symptom Perception and Quality of Life Burdens.Am J Rhinol Allergy. 2020 Nov;34(6):742-750. doi: 10.1177/1945892420927244. Epub 2020 May 21. Am J Rhinol Allergy. 2020. PMID: 32437223
-
Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis.Laryngoscope. 2006 Jul;116(7 Pt 2 Suppl 110):1-22. doi: 10.1097/01.mlg.0000224508.59725.19. Laryngoscope. 2006. PMID: 16826087 Clinical Trial.
-
Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management.Int Forum Allergy Rhinol. 2015 Jan;5(1):36-45. doi: 10.1002/alr.21410. Epub 2014 Sep 18. Int Forum Allergy Rhinol. 2015. PMID: 25236780 Free PMC article. Clinical Trial.
-
Reduced Sense of Smell in Patients with Severe Chronic Rhinosinusitis and its Implications for Diagnosis and Management: A Narrative Review.Adv Ther. 2024 Dec;41(12):4384-4395. doi: 10.1007/s12325-024-02984-w. Epub 2024 Oct 9. Adv Ther. 2024. PMID: 39382822 Free PMC article. Review.
-
Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis.Laryngoscope. 2001 Mar;111(3):409-23. doi: 10.1097/00005537-200103000-00008. Laryngoscope. 2001. PMID: 11224769 Free PMC article. Review.
Cited by
-
Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literature.Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5345-5352. doi: 10.1007/s00405-023-08090-x. Epub 2023 Jun 28. Eur Arch Otorhinolaryngol. 2023. PMID: 37378726
-
Current understanding of disease control and its application in patients with chronic rhinosinusitis.Front Cell Infect Microbiol. 2023 Jun 5;13:1104444. doi: 10.3389/fcimb.2023.1104444. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37342244 Free PMC article.
-
Patient perspectives on international multidisciplinary consensus criteria for chronic rhinosinusitis disease control.Laryngoscope Investig Otolaryngol. 2024 Sep 14;9(5):e70005. doi: 10.1002/lio2.70005. eCollection 2024 Oct. Laryngoscope Investig Otolaryngol. 2024. PMID: 39281205 Free PMC article.
-
Dedicated Olfaction and Taste Items do not Improve Psychometric Performance of the SNOT-22.Laryngoscope. 2022 Aug;132(8):1644-1651. doi: 10.1002/lary.30120. Epub 2022 Mar 30. Laryngoscope. 2022. PMID: 35353381 Free PMC article.
-
Patient-centered outcomes for clinical trials in chronic rhinosinusitis with or without nasal polyps and allergic fungal rhinosinusitis.J Patient Rep Outcomes. 2025 Jan 23;9(1):11. doi: 10.1186/s41687-024-00833-6. J Patient Rep Outcomes. 2025. PMID: 39847130 Free PMC article. Review.
References
BIBLIOGRAPHY
-
- Sedaghat AR, Hoehle LP, Gray ST. Chronic rhinosinusitis control from the patient and physician perspectives. Laryngoscope Investig Otolaryngol 2018;3:419-433.
-
- EPR-3. NAEPP expert panel report 3: guidelines for the diagnosis and treatment of asthma. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; 2007.
-
- Joint Task Force on Practice Parameters AAoAA, Immunology, American College of Allergy A, Immunology, Joint Council of Allergy A, Immunology. Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol 2005;116:S3-11.
-
- Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015;46:622-639.
-
- Abrams EM, Becker AB, Szefler SJ. Use of oral corticosteroids in the wheezy toddler. J Pediatr 2018;201:16-20.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials